Skip to main content

Table 6 Characteristics of lung cancer among patients having thoracic surgery and non-thoracic surgery

From: Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients

 

All cases (n = 185)

Non-surgery (n = 50)

Surgery (n = 135)

p value

Lung cancer histology

   

0.028 #

Adenocarcinoma

58.4 (108)

44.0 (22)

63.7 (86) ##

 

Sq

30.8 (57)

38.0 (19)

28.1 (38)

 

NSCLC

5.4 (10)

10.0 (5)

7.4 (10)

 

SCLC

3.2 (6)

8.0 (4)

1.5 (2) ##

 

Large

2.2 (4)

0 (0)

3.0 (4)

 

Clinical stage

   

0.0001 #

1A

37.3 (69)

26.0 (13)

41.5 (56)

 

1B

19.4 (36)

14.0 (7)

21.5 (29)

 

2A

14.6 (27)

10.0 (5)

16.3(22)

 

2B

11.4 (21)

8.0 (4)

12.6 (17)

 

3A

17.3 (32)

42.0 (21)

8.1 (11) ##

 

EGFR status

   

0.0001 #

Yes

16.2 (30)

8.0 (4)

19.3 (26)

 

No

61.6 (114)

28.0 (14)

74.1 (100) ##

 

ND

22.2 (41)

64.0 (32)

6.7 (9) ##

 
  1. n indicates number.
  2. aData are shown as mean (range). bData are shown as mean (SD).
  3. All other data are shown as% (numbers).
  4. ND indicates “not determined”.
  5. #p < 0.05.
  6. ##indicates a significant difference compared with the non-surgery group.
  7. Sq: squamous cell carcinoma; NSCLC: non-small cell lung carcinoma; SCLC: small cell lung carcinoma; Large: large cell carcinoma; EGFR: epidermal growth factor receptor.